The company had reported a net profit of Rs 1.51 crore for the corresponding period of the previous fiscal, AstraZeneca Pharma said in a filing to BSE.
The company's standalone total income from operations stood at Rs 108.20 crore for the quarter under consideration.
Also Read
It was Rs 118.95 crore for the same period a year ago.
Shares of AstraZeneca Pharma India were trading 0.18% down at Rs 867 per scrip during afternoon session on the BSE.